US58506Q1094
US58506Q1094
Medpace Holdings, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 17.08B EUR | 14.78B EUR | 13.71B EUR | 15.93B EUR |
Enterprise Value | 16.46B EUR | 14.4B EUR | 13.18B EUR | 15.55B EUR |
Valuation Multiples | ||||
Trailing P/E | 35.94x | 30.07x | 29.79x | 47.35x |
Forward P/E | 31.69x | -- | -- | -- |
Price to Sales | 6.14x | 5.31x | 5.12x | 8.08x |
Price to Book | 39.37x | 34.07x | 22.92x | 34.71x |
EV/Revenue | 5.92x | 5.18x | 4.92x | 7.89x |
EV/EBITDA | 26.94x | 23.56x | 22.31x | 35.14x |
Price to FCF (P/FCF) | 33.47x | 20.92x | 19.29x | 28.15x |
EV/FCF | 32.26x | 20.37x | 18.54x | 27.47x |
FCF Yield | 2.99% | 4.78% | 5.18% | 3.55% |